These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 25634471

  • 1. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
    Prada P, Nicastro R, Zimmermann J, Hasler R, Aubry JM, Perroud N.
    Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of methylphenidate on decision making in patients with borderline personality disorder and attention-deficit/hyperactivity disorder.
    Gvirts HZ, Lewis YD, Dvora S, Feffer K, Nitzan U, Carmel Z, Levkovitz Y, Maoz H.
    Int Clin Psychopharmacol; 2018 Jul; 33(4):233-237. PubMed ID: 29847836
    [Abstract] [Full Text] [Related]

  • 4. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.
    Kolko DJ, Bukstein OG, Barron J.
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample.
    Philipsen A, Graf E, Jans T, Matthies S, Borel P, Colla M, Gentschow L, Langner D, Jacob C, Groß-Lesch S, Sobanski E, Alm B, Schumacher-Stien M, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Heinrich V, Huss M, Kornmann C, Bürger A, van Elst LT, Berger M.
    Atten Defic Hyperact Disord; 2014 Mar; 6(1):35-47. PubMed ID: 24132867
    [Abstract] [Full Text] [Related]

  • 6. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
    Lam AP, Matthies S, Graf E, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Müller HHO, Lücke C, Huss M, Jans T, Berger M, Tebartz van Elst L, Philipsen A, Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium.
    JAMA Netw Open; 2019 May 03; 2(5):e194980. PubMed ID: 31150084
    [Abstract] [Full Text] [Related]

  • 7. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.
    Clin Psychol Psychother; 2012 May 03; 19(3):270-8. PubMed ID: 21404369
    [Abstract] [Full Text] [Related]

  • 8. Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder.
    Ferrer M, Andión O, Matalí J, Valero S, Navarro JA, Ramos-Quiroga JA, Torrubia R, Casas M.
    J Pers Disord; 2010 Dec 03; 24(6):812-22. PubMed ID: 21158602
    [Abstract] [Full Text] [Related]

  • 9. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.
    Eur Neuropsychopharmacol; 2013 Dec 03; 23(12):1714-23. PubMed ID: 23731497
    [Abstract] [Full Text] [Related]

  • 10. Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.
    Victor MM, Rovaris DL, Salgado CA, Silva KL, Karam RG, Vitola ES, Picon FA, Contini V, Guimarães-da-Silva PO, Blaya-Rocha P, Belmonte-de-Abreu PS, Rohde LA, Grevet EH, Bau CH.
    J Clin Psychopharmacol; 2014 Apr 03; 34(2):212-7. PubMed ID: 24577256
    [Abstract] [Full Text] [Related]

  • 11. Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
    Robison RJ, Reimherr FW, Gale PD, Marchant BK, Williams ED, Soni P, Halls C, Strong RE.
    Ann Clin Psychiatry; 2010 May 03; 22(2):94-102. PubMed ID: 20445836
    [Abstract] [Full Text] [Related]

  • 12. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
    Winters DE, Fukui S, Leibenluft E, Hulvershorn LA.
    J Child Adolesc Psychopharmacol; 2018 Jun 03; 28(5):298-305. PubMed ID: 29708762
    [Abstract] [Full Text] [Related]

  • 13. [Attention deficit disorder: multidisciplinary observational study over 1 year].
    Chambry J, Billard C, Guinard M, Lacaze E, Idiart ME, Delteil-Pinton F, Cohen de Lara A.
    Encephale; 2011 Jun 03; 37(3):180-90. PubMed ID: 21703433
    [Abstract] [Full Text] [Related]

  • 14. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P, Kodesh A, Weizman A.
    Clin Neuropharmacol; 2013 Jun 03; 36(5):141-5. PubMed ID: 24045603
    [Abstract] [Full Text] [Related]

  • 15. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults.
    Asherson P, Young AH, Eich-Höchli D, Moran P, Porsdal V, Deberdt W.
    Curr Med Res Opin; 2014 Aug 03; 30(8):1657-72. PubMed ID: 24804976
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study.
    Mattos P, Louzã MR, Palmini AL, de Oliveira IR, Rocha FL.
    J Atten Disord; 2013 Jul 03; 17(5):444-8. PubMed ID: 22334621
    [Abstract] [Full Text] [Related]

  • 17. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
    Rösler M, Retz W, Fischer R, Ose C, Alm B, Deckert J, Philipsen A, Herpertz S, Ammer R.
    World J Biol Psychiatry; 2010 Aug 03; 11(5):709-18. PubMed ID: 20353312
    [Abstract] [Full Text] [Related]

  • 18. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P, Weizman A.
    J Child Adolesc Psychopharmacol; 2017 Jun 03; 27(5):429-432. PubMed ID: 28398816
    [Abstract] [Full Text] [Related]

  • 19. Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders.
    Golubchik P, Sever J, Weizman A.
    Clin Neuropharmacol; 2009 Jun 03; 32(5):239-42. PubMed ID: 19834989
    [Abstract] [Full Text] [Related]

  • 20. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N, Rolland B, Karila L.
    Curr Pharm Des; 2015 Jun 03; 21(23):3359-66. PubMed ID: 26088112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.